These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8387543)
1. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. Naylor MS; Stamp GW; Foulkes WD; Eccles D; Balkwill FR J Clin Invest; 1993 May; 91(5):2194-206. PubMed ID: 8387543 [TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression. Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577 [TBL] [Abstract][Full Text] [Related]
3. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Kulbe H; Hagemann T; Szlosarek PW; Balkwill FR; Wilson JL Cancer Res; 2005 Nov; 65(22):10355-62. PubMed ID: 16288025 [TBL] [Abstract][Full Text] [Related]
4. Molecular, biochemical, and functional characteristics of tumor necrosis factor-alpha produced by human placental cytotrophoblastic cells. Yang Y; Yelavarthi KK; Chen HL; Pace JL; Terranova PF; Hunt JS J Immunol; 1993 Jun; 150(12):5614-24. PubMed ID: 8390539 [TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor expression by human ovarian carcinoma in vivo. Takeyama H; Wakamiya N; O'Hara C; Arthur K; Niloff J; Kufe D; Sakarai K; Spriggs D Cancer Res; 1991 Aug; 51(16):4476-80. PubMed ID: 1868469 [TBL] [Abstract][Full Text] [Related]
6. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994 [TBL] [Abstract][Full Text] [Related]
7. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer. Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Pujol P; Rey JM; Nirde P; Roger P; Gastaldi M; Laffargue F; Rochefort H; Maudelonde T Cancer Res; 1998 Dec; 58(23):5367-73. PubMed ID: 9850067 [TBL] [Abstract][Full Text] [Related]
9. [Tumor necrosis factor gene expression in ovarian tumor]. Gao SF; Zhang SZ; Zhang MH Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):389-91, 443. PubMed ID: 8001412 [TBL] [Abstract][Full Text] [Related]
10. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863 [TBL] [Abstract][Full Text] [Related]
11. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814 [TBL] [Abstract][Full Text] [Related]
12. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936 [TBL] [Abstract][Full Text] [Related]
13. Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes. Lichtenstein A; Berenson J; Gera JF; Waldburger K; Martinez-Maza O; Berek JS Cancer Res; 1990 Nov; 50(22):7364-70. PubMed ID: 1977519 [TBL] [Abstract][Full Text] [Related]
14. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. Kerkelä E; Ala-aho R; Klemi P; Grénman S; Shapiro SD; Kähäri VM; Saarialho-Kere U J Pathol; 2002 Oct; 198(2):258-69. PubMed ID: 12237887 [TBL] [Abstract][Full Text] [Related]
15. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms. Wang P; Wu X; Chen W; Liu J; Wang X Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312 [TBL] [Abstract][Full Text] [Related]
16. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression. Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176 [TBL] [Abstract][Full Text] [Related]
17. Activation of androgen receptor-associated protein 70 (ARA70) mRNA expression in ovarian cancer. Shaw PA; Rittenberg PV; Brown TJ Gynecol Oncol; 2001 Feb; 80(2):132-8. PubMed ID: 11161850 [TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer. Barton DP; Blanchard DK; Wells AF; Nicosia SV; Roberts WS; Cavanagh D; Djeu JY Anticancer Res; 1994; 14(3A):761-72. PubMed ID: 8074478 [TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors. Kost ER; Mutch DG; Herzog TJ Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112 [TBL] [Abstract][Full Text] [Related]
20. Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells. Yang WL; Roland IH; Godwin AK; Xu XX Oncogene; 2005 Dec; 24(54):7991-8002. PubMed ID: 16044148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]